United States · Series B startup

Who invested in Granite Bio

One round we have observed, with the 4 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechPharma

Funding summaryUpdated 15 Nov 2026

$70Mraised across 1 round since 2025, from 1 source

Latest round
Series B, $70MApr 2025
Led by
Forbion Capital Partners and Sanofi
Investors
4 (2 led)
See who backed them

The rounds

  1. Apr 2025

Everyone who backed them

Forbion Capital PartnersPrivate equity1round, led 1
SanofiInvestment firm1round, led 1
Versant VenturesVC firm1round
NovartisVC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Granite Bio

Who invested in Granite Bio?

Granite Bio's investors include Forbion Capital Partners, Sanofi, Versant Ventures and Novartis. Forbion Capital Partners led its latest round.

How much has Granite Bio raised?

Granite Bio has raised $70M across 1 round since 2025.

When did Granite Bio last raise?

Granite Bio's most recent round was a Series B of $70M in Apr 2025, led by Forbion Capital Partners.

What was Granite Bio's biggest round?

Its most recent round, $70M in Apr 2025, is also its largest on record.

Who backed Granite Bio first?

Granite Bio's first round on record, in Apr 2025, was backed by Forbion Capital Partners, Sanofi and Versant Ventures and 1 others.

What stage is Granite Bio at?

Granite Bio's latest named round is a Series B, in Apr 2025.

Where is Granite Bio based?

Granite Bio is based in the United States.

Who led Granite Bio's rounds?

Forbion Capital Partners led the Series B in 2025.

Companies like Granite Bio

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.